Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.

Disturbances in cardiovascular neural regulation, influencing both disease course and survival, progress as heart failure worsens. Heart failure due to left ventricular systolic dysfunction has long been considered a state of generalized sympathetic activation, itself a reflex response to alterations in cardiac and peripheral hemodynamics that is initially appropriate, but ultimately pathological. Because arterial baroreceptor reflex vagal control of heart rate is impaired early in heart failure, a parallel reduction in its reflex buffering of sympathetic outflow has been assumed. However, it is now recognized that: 1) the time course and magnitude of sympathetic activation are target organ-specific, not generalized, and independent of ventricular systolic function; and 2) human heart failure is characterized by rapidly responsive arterial baroreflex regulation of muscle sympathetic nerve activity (MSNA), attenuated cardiopulmonary reflex modulation of MSNA, a cardiac sympathoexcitatory reflex related to increased cardiopulmonary filling pressure, and by individual variation in nonbaroreflex-mediated sympathoexcitatory mechanisms, including coexisting sleep apnea, myocardial ischemia, obesity, and reflexes from exercising muscle. Thus, sympathetic activation in the setting of impaired systolic function reflects the net balance and interaction between appropriate reflex compensatory responses to impaired systolic function and excitatory stimuli that elicit adrenergic responses in excess of homeostatic requirements. Recent observations have been incorporated into an updated model of cardiovascular neural regulation in chronic heart failure due to ventricular systolic dysfunction, with implications for the clinical evaluation of patients, application of current treatment, and development of new therapies.

[1]  R. Weiss,et al.  Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.

[2]  D. Ferguson,et al.  Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. , 1990, Journal of the American College of Cardiology.

[3]  E. Vizi,et al.  Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. , 1994, Cardiovascular research.

[4]  J S Floras,et al.  Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure. , 2001, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  J. Floras,et al.  Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle. , 1995, Circulation.

[6]  M. Thames,et al.  Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. , 1996, Journal of the American College of Cardiology.

[7]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[8]  M. Naughton,et al.  Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. , 1995, American journal of respiratory and critical care medicine.

[9]  BengtRundqvist,et al.  Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure , 1997 .

[10]  K. Umeno,et al.  Respiratory Modulation of Muscle Sympathetic Nerve Activity in Patients With Chronic Heart Failure , 2001, Circulation.

[11]  W. Dupont,et al.  Ethnic and Genetic Determinants of Cardiovascular Response to the Selective &agr;2-Adrenoceptor Agonist Dexmedetomidine , 2008, Hypertension.

[12]  D. Ferguson,et al.  Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct micronenrographic recordings , 1990 .

[13]  M. Piepoli,et al.  Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. , 1996, Clinical science.

[14]  S. Ando,et al.  Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea , 2005, Hypertension.

[15]  G. Tomlinson,et al.  Influence of obstructive sleep apnea on mortality in patients with heart failure. , 2007, Journal of the American College of Cardiology.

[16]  C. Liang,et al.  Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. , 1994, The American journal of physiology.

[17]  N. de Luca,et al.  Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. , 1991, The Journal of clinical investigation.

[18]  R. Weiss,et al.  Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure , 2006, Circulation Research.

[19]  M. Emdin,et al.  Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. , 2008, Clinical science.

[20]  Lie Gao,et al.  Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase , 2004, Circulation research.

[21]  J. Floras,et al.  Respiratory correlates of muscle sympathetic nerve activity in heart failure. , 1998, Clinical science.

[22]  A. Logan,et al.  Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. , 2003, Chest.

[23]  J. Floras,et al.  Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure. , 2007, Journal of cardiac failure.

[24]  J. Floras,et al.  Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. , 2001, American journal of physiology. Heart and circulatory physiology.

[25]  J. Skatrud,et al.  Exposure to hypoxia produces long-lasting sympathetic activation in humans. , 2001, Journal of applied physiology.

[26]  G. Pickering,et al.  Reflex Regulation of Arterial Pressure during Sleep in Man: A Quantitative Method of Assessing Baroreflex Sensitivity , 1969, Circulation research.

[27]  H. Middlekauff,et al.  Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.

[28]  J S Floras,et al.  Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. , 1997, The American journal of physiology.

[29]  W. White,et al.  Ambulatory Monitoring of Blood Pressure , 2001 .

[30]  M. Esler,et al.  Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure , 2002, Circulation.

[31]  E. Potter,et al.  Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat. , 1999, Journal of the autonomic nervous system.

[32]  M. Esler,et al.  beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. , 2001, Lancet.

[33]  J S Floras,et al.  Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. , 1999, American journal of respiratory and critical care medicine.

[34]  G Mancia,et al.  Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.

[35]  J. Brown,et al.  Further characterization of the presynaptic alpha-1 receptor modulating [3H]ACh release from rat atria. , 1986, The Journal of pharmacology and experimental therapeutics.

[36]  S. Ando,et al.  Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine. , 1998, The Journal of clinical investigation.

[37]  N. Montano,et al.  Altered cardiovascular variability in obstructive sleep apnea. , 1998, Circulation.

[38]  J. Dempsey,et al.  Carotid Chemoreceptor Modulation of Regional Blood Flow Distribution During Exercise in Health and Chronic Heart Failure , 2007, Circulation research.

[39]  P. Sleight,et al.  Scientific Foundations of Cardiology , 1985 .

[40]  C. Liang,et al.  Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure. , 2000, American journal of physiology. Heart and circulatory physiology.

[41]  P. Picton,et al.  Vagal heart rate responses to chronic beta‐blockade in human heart failure relate to cardiac norepinephrine spillover , 2005, European journal of heart failure.

[42]  G. Newton,et al.  Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure. , 1996, Circulation.

[43]  M. Bristow Changes in myocardial and vascular receptors in heart failure. , 1993, Journal of the American College of Cardiology.

[44]  A. Quyyumi,et al.  Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.

[45]  Robin M McAllen,et al.  Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure , 2009, Proceedings of the National Academy of Sciences.

[46]  I. Zucker,et al.  Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs. , 1996, Journal of applied physiology.

[47]  M. Böhm,et al.  Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.

[48]  M. Thames,et al.  Effect of chronic myocardial infarction on vagal cardiopulmonary baroreflex. , 1989, Circulation research.

[49]  J. Floras Arterial Baroreceptor and Cardiopulmonary Reflex Control of Sympathetic Outflow in Human Heart Failure , 2001, Annals of the New York Academy of Sciences.

[50]  M. Esler,et al.  β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure , 2001, The Lancet.

[51]  G. Eisenhofer,et al.  Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart. , 1997, American journal of physiology. Heart and circulatory physiology.

[52]  A. Mark,et al.  Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. , 1996, Circulation.

[53]  S. Ando,et al.  Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. , 2003 .

[54]  I. Zucker,et al.  Reduced NO enhances the central gain of cardiac sympathetic afferent reflex in dogs with heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.

[55]  H. Middlekauff,et al.  The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. , 2003, Journal of the American College of Cardiology.

[56]  M. Pfeffer,et al.  Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. , 2002, Journal of the American College of Cardiology.

[57]  S. Yusuf,et al.  Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. , 1993, Journal of the American College of Cardiology.

[58]  G. Wallukat,et al.  Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. , 1994, Circulation.

[59]  W. Wang,et al.  Volume expansion potentiates cardiac sympathetic afferent reflex in dogs. , 2001, American journal of physiology. Heart and circulatory physiology.

[60]  G. Jennings,et al.  Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. , 1994, Journal of the American College of Cardiology.

[61]  S. Ando,et al.  Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. , 1999, European heart journal.

[62]  W. Wang,et al.  Cardiac sympathetic afferent sensitivity is enhanced in heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.

[63]  T. Young,et al.  Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. , 2006, Archives of internal medicine.

[64]  J. Floras Chapter 16 – Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure , 2011 .

[65]  D P Zipes,et al.  Influence of Myocardial Ischemia and Infarction on Autonomic Innervation of Heart , 1990, Circulation.

[66]  M. Esler,et al.  Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity , 2003, Circulation.

[67]  F. Leenen Brain mechanisms contributing to sympathetic hyperactivity and heart failure. , 2007, Circulation research.

[68]  G. Tomlinson,et al.  Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure: A Post Hoc Analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP) , 2007, Circulation.

[69]  Daly Pa,et al.  Myocardial catecholamines and the pathophysiology of heart failure. , 1990 .

[70]  G. Jennings,et al.  Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.

[71]  J. Parker,et al.  Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure , 2004, Circulation.

[72]  A. Vallbo,et al.  Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. , 2004, Journal of applied physiology.

[73]  M. Lab,et al.  Contribution to heart rate variability by mechanoelectric feedback. Stretch of the sinoatrial node reduces heart rate variability. , 1996, Circulation.

[74]  R. Page,et al.  Biventricular Pacing Decreases Sympathetic Activity Compared With Right Ventricular Pacing in Patients With Depressed Ejection Fraction , 2000, Circulation.

[75]  V. Somers,et al.  Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. , 1999, Circulation.

[76]  Z. Topor,et al.  Dynamic ventilatory response to CO(2) in congestive heart failure patients with and without central sleep apnea. , 2001, Journal of applied physiology.

[77]  H. Dajani,et al.  Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea , 2000, Journal of hypertension.

[78]  P. Ernsberger,et al.  Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. , 2003, American journal of physiology. Heart and circulatory physiology.

[79]  Roberto Maestri,et al.  Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. , 2009, Journal of the American College of Cardiology.

[80]  A. Dart,et al.  Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. , 1998, Journal of the American College of Cardiology.

[81]  G. Breithardt,et al.  Ischemic versus idiopathic cardiomyopathy: differing neurohumoral profiles despite comparable peak oxygen uptake. , 1997, International journal of cardiology.

[82]  J. Floras,et al.  Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. , 2005, Journal of the American College of Cardiology.

[83]  P. Ponikowski,et al.  Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. , 1997, European heart journal.

[84]  H. Figulla,et al.  Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  S. Kardia,et al.  Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .

[86]  J. Floras,et al.  Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure. , 2000, Journal of cardiovascular pharmacology.

[87]  G. Mancia,et al.  Sympathetic Response to Ventricular Extrasystolic Beats in Hypertension and Heart Failure , 2002, Hypertension.

[88]  J. Floras Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. , 1993, Journal of the American College of Cardiology.

[89]  J S Floras,et al.  Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure. , 1997, Circulation.

[90]  D. Paterson,et al.  Should we still use nitrovasodilators to test baroreflex sensitivity? , 2000, Journal of hypertension.

[91]  S. Ando,et al.  Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure. , 1999, Circulation.

[92]  Yanfeng Ding,et al.  Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. , 2007, Hypertension.

[93]  T Douglas Bradley,et al.  Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. , 2003, The New England journal of medicine.

[94]  R. Weiss,et al.  Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure? , 2008, Hypertension.

[95]  J. J. Smith,et al.  Effects of aging on baroreflex regulation of sympathetic activity in humans. , 1992, The American journal of physiology.

[96]  D. Ferguson,et al.  Effects of heart failure on baroreflex control of sympathetic neural activity. , 1992, The American journal of cardiology.

[97]  Giuseppe Mancia,et al.  Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients , 2003, Hypertension.

[98]  W. Hundley,et al.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.

[99]  M. Esler,et al.  Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure , 2001, Circulation.

[100]  S. Goldsmith,et al.  Angiotensin II and sympathetic activity in patients with congestive heart failure. , 1993, Journal of the American College of Cardiology.

[101]  A. Malliani,et al.  Emerging Excitatory Role of Cardiovascular Sympathetic Afferents in Pathophysiological Conditions , 2002, Hypertension.

[102]  M. Guazzi,et al.  Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. , 1994, The American journal of medicine.

[103]  S. Rucki [Ambulatory monitoring of blood pressure--focus on childhood]. , 2000, Casopis lekaru ceskych.

[104]  I. Zucker Brain angiotensin II: new insights into its role in sympathetic regulation. , 2002, Circulation research.

[105]  M. Esler,et al.  Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. , 2001, Journal of the American College of Cardiology.

[106]  J. Parker,et al.  Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. , 1999, Circulation.

[107]  G. Mancia,et al.  Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. , 2001, Clinical science.

[108]  C. Kappagoda,et al.  The rapidly adapting receptors in mammalian airways and their responses to changes in extravascular fluid volume , 2006, Experimental physiology.

[109]  M. Esler,et al.  Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. , 2004, Journal of the American College of Cardiology.

[110]  G. Grassi,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.

[111]  E. Irwin,et al.  Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure , 2007, Hypertension.

[112]  G. Lambert,et al.  Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure * , 2005, European journal of heart failure.

[113]  T. Lüscher,et al.  Nasal oxygen and muscle sympathetic nerve activity in heart failure. , 2003, Chest.

[114]  W. Wang,et al.  Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs. , 1999, The American journal of physiology.

[115]  S. Ando,et al.  Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. , 2001, Chest.

[116]  K J Osterziel,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1996, Circulation.

[117]  F. Abboud,et al.  Sympathetic-nerve activity during sleep in normal subjects. , 1993, The New England journal of medicine.

[118]  J. Floras The "unsympathetic" nervous system of heart failure. , 2002, Circulation.

[119]  P. Linkowski,et al.  Effects of wake and sleep stages on the 24-h autonomic control of blood pressure and heart rate in recumbent men. , 1994, The American journal of physiology.

[120]  J. Floras,et al.  Nonselective Versus Selective &bgr;-Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity , 2001, Circulation.

[121]  J. Floras,et al.  Effects of forearm venous occlusion on peroneal muscle sympathetic nerve activity in healthy subjects. , 1995, The American journal of cardiology.

[122]  F. Abboud,et al.  Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.

[123]  W. Klein,et al.  Routine lipid profile in patients with and without restenosis after percutaneous transluminal coronary angioplasty. , 1992, The American journal of cardiology.

[124]  I. Reid Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. , 1992, The American journal of physiology.

[125]  T. LeJemtel,et al.  Heart Rate Variability and Diastolic Heart Failure , 2004, Pacing and clinical electrophysiology : PACE.

[126]  T. Lohmeier,et al.  Influence of Prolonged Baroreflex Activation on Arterial Pressure in Angiotensin Hypertension , 2005, Hypertension.

[127]  J. Floras,et al.  Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.

[128]  R. Neubig,et al.  Phagocyte-derived catecholamines enhance acute inflammatory injury , 2007, Nature.

[129]  I. Zucker,et al.  Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. , 1997, The American journal of physiology.

[130]  M. Dibner-Dunlap Arterial or cardiopulmonary baroreflex control of sympathetic nerve activity in heart failure? , 1992, The American journal of cardiology.

[131]  T. Nozawa,et al.  Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure. , 2004, Journal of cardiac failure.

[132]  I. Zucker,et al.  Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure , 2006, Hypertension.

[133]  S. Javaheri Pembrey's dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. , 2003, Chest.

[134]  A. Gebert,et al.  Luminal antigens access late endosomes of intestinal epithelial cells enriched in MHC I and MHC II molecules: in vivo study in Crohn's ileitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[135]  D. McCloskey,et al.  Inhibition by angiotensin II of baroreceptor‐evoked activity in cardiac vagal efferent nerves in the dog. , 1979, The Journal of physiology.

[136]  J. Floras,et al.  Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. , 2000, Circulation.

[137]  J. McMurray,et al.  Neurohumoral pathways in heart failure with preserved systolic function. , 2005, Progress in cardiovascular diseases.

[138]  D L Eckberg,et al.  Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.

[139]  L. Graham,et al.  Time Course of Sympathetic Neural Hyperactivity After Uncomplicated Acute Myocardial Infarction , 2002, Circulation.

[140]  P. Ponikowski,et al.  Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure , 2001, Circulation.

[141]  Francois M. Abboud,et al.  Interaction of Cardiovascular Reflexes in Circulatory Control , 2011 .

[142]  M. N. Levy,et al.  Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. , 1980, The American journal of physiology.

[143]  G. Fonarow,et al.  Muscle mechanoreceptor sensitivity in heart failure. , 2004, American journal of physiology. Heart and circulatory physiology.

[144]  C. May,et al.  Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. , 2007, American journal of physiology. Heart and circulatory physiology.

[145]  G. Jennings,et al.  Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. , 1995, Circulation.

[146]  R. Wenzel Diuretics in heart failure. , 1986, Lancet.

[147]  P. Binkley,et al.  Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. , 1991, Journal of the American College of Cardiology.